创伤性B型主动脉夹层的诊疗进展  

Advances in diagnosis and treatment of traumatic type B aortic dissection

作　　者：王伦常 覃淇 舒畅[1,2] WANG Lunchang;QIN Qi;SHU Chang(Department of Vascular Surgery,The Second Xiangya Hospital,Central South University/Insititute of Vascular Disease,Central South University/Clinical Research Center for Vascular Disease in Hunan Province,Changsha 410011,Hunan,China;Central of Vascular Surgery,Fuwai Hospital,Chinese Academy of Medical Science,Beijing 100037,China)

机构地区：[1]中南大学湘雅二医院血管外科中南大学血管病研究所湖南省血管疾病临床研究中心,湖南长沙410011 [2]中国医学科学院阜外医院血管中心,北京100037

出　　处：《山东大学学报（医学版）》2024年第9期19-25,共7页Journal of Shandong University:Health Sciences

基　　金：重点国际(地区)合作研究项目(82120108005);国家自然科学基金(81900423);湖南省自然科学基金项目(S2023JJMSXM2823)。

摘　　要：本文聚焦于创伤性B型主动脉夹层(traumatic type B aortic dissection, TTBAD)的临床研究进展,总结其发病机制、临床特点与诊断、严重程度划分、治疗方法与预后随访。TTBAD常见于创伤多发伤患者,早期准确诊断至关重要,损伤严重程度是决定TTBAD患者治疗策略与预后的关键,治疗上强调多学科协作,药物治疗和胸主动脉腔内修复术成为主要的治疗选择。但在不同严重程度TTBAD患者的治疗策略与手术时机选择上仍存在一定争议。This article focuses on the clinical research advancements in traumatic type B aortic dissection(TTBAD),and summarized its pathogenesis,clinical features and diagnosis,severity classification,treatment modalities,and follow-up prognosis.TTBAD is commonly observed in patients with multiple trauma injuries,and making early and accurate diagnosis is imperative.The severity of the injury is a critical determinant in deciding the treatment strategy and prognosis for TTBAD patients.Treatment emphasizes a multidisciplinary approach,with pharmacotherapy and thoracic endovascular aortic repair(TEVAR)being the primary options.However,there remains some controversy regarding treatment strategies and the timing of surgery in patients with varying severities of TTBAD.

关 键 词：主动脉夹层 创伤 胸主动脉腔内修复术 手术时机 

分 类 号：R654.3[医药卫生—外科学]